Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva (ACT)

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Lund University Hospital
ClinicalTrials.gov Identifier:
NCT00598156
First received: January 9, 2008
Last updated: April 19, 2013
Last verified: April 2013